Collaboration Announcement: Pfizer x Helical
Helical and Pfizer are putting the Virtual Lab to work, discovering predictive blood-based safety biomarkers in production for biomarker discovery.
Turning foundation models into actionable systems for biologists
Two years ago, this was a thesis. Today, we are proud to share what we have been building with Pfizer. Helical and Pfizer have been collaborating to bring AI-driven insights into production for biomarker discovery.
Pfizer's scientists were early to recognize that the real challenge is not only building foundation models. It is turning them into systems that deliver results biologists can evaluate, trust, and act on. That is the Virtual Lab, and it is exactly where Helical operates.
Together, we have been discovering predictive blood-based safety biomarkers, enabling the right patients to get the right treatment, sooner and safer. We do this by personalizing foundation models to Pfizer's disease context, and grounding every output in biological evidence their teams can understand, evaluate, and ultimately validate.
We are excited to see the impact this collaboration will have on Pfizer's already world-class discovery capabilities. And this is just the beginning.
Get started
About Helical
Helical is the virtual AI lab for pharma. We are the application layer that orchestrates the world's best bio foundation models, aligned to your biology, so pharma and biotech teams can run scalable, reproducible in-silico experiments across target discovery, biomarker development, patient stratification, and RNA therapy design.
Check out our
open-source libraryFollow or subscribe to stay up-to-date with the latest developments in Bio Foundation Models.
